Search results
Found 7347 matches for
Oxford Sciences Innovation (OSI) recently announced the acquisition of its portfolio company, Base Genomics, by US-based early cancer diagnostic leaders, Exact Sciences, for $410m. The partnership will enable Base Genomics to significantly accelerate its clinical and commercial development here in Oxford, potentially unlocking a new era of preventative medicine and improved patient outcomes.
MLSTF Summer 2024 - Minutes
Minutes from MLSTF 2024 Panel meeting
Guidance For Applicants FA Alliance Catalyst
Guidance For Applicants